E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedReviewed
Standard · 3 min
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.
Stieler, Kristin, Fischer, Nicole · PloS one · 2010 · DOI
Quick Summary
This study examined how a virus called XMRV (which has been suspected in ME/CFS) interacts with human immune defense proteins called Apobec3 proteins. Researchers found that one specific immune protein, called A3G, is very effective at stopping XMRV from infecting cells and spreading. Interestingly, cancer cells that are easily infected by XMRV don't produce much of this protective A3G protein.
Why It Matters
Understanding how immune proteins control XMRV infection is crucial if XMRV is indeed involved in ME/CFS, as it may explain why some cells become infected and why the virus might persist in certain tissues. The discovery that cancer cells permissive to XMRV lack protective A3G suggests potential mechanisms for viral tropism and persistence that could inform future research on XMRV's role in chronic illness.
Observed Findings
XMRV is highly susceptible to human A3G (hA3G) protein, which potently reduces viral infectivity
XMRV is resistant to human Apobec3B, 3C, and 3F proteins
Prostate cancer cell lines permissive to XMRV infection express little or no hA3G protein
Both XMRV and MoMLV virions package Apobec proteins regardless of their restriction activity
XMRV infectivity can be partially reduced by low concentrations of mouse A3 (mA3), unlike MoMLV
Inferred Conclusions
A3G is a potent restriction factor for XMRV infection, consistent with its antiviral role against most retroviruses
The lack of hA3G expression in cancer cell lines explains their high permissiveness to XMRV infection
XMRV tropism and tissue-specific infection patterns may be partly determined by A3G expression levels in different cell types
The observation that mA3 partially restricts XMRV suggests potential natural reservoirs for the virus in other species
Remaining Questions
Does XMRV actually infect human tissues in vivo, and do infected tissues have different A3G expression profiles?
What This Study Does Not Prove
This study does not prove that XMRV causes ME/CFS or that it is present in ME/CFS patients. It is an in vitro mechanistic study showing only that A3G can restrict XMRV infection in cell culture—it does not establish the virus's actual tissue distribution, prevalence, or pathogenic role in humans. The study cannot determine whether abnormal A3G expression occurs in ME/CFS patients.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.